Academic Seminars

EMMPRIN/CD147: A Novel Molecular Target for Acute Stroke Therapy
March 11, 2016

Stroke is the third leading cause of death in the U.S. and the most common cause of disability. In this talk, I will present new findings from our study exploring CD147 as a novel molecular target for stroke therapy.